STOK•benzinga•
HC Wainwright & Co. Maintains Buy on Stoke Therapeutics, Raises Price Target to $47
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 18, 2025 by benzinga